Skip to content
naulon

Not checkedNot checked for notices yet.

Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases

David Beran, Margaret Ewen, Christophe Perrin and 9 more

BMJ Global Health · 2025

doi:10.1136/bmjgh-2025-019355 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Non-communicable diseases (NCDs) include cancers, cardiovascular diseases, diabetes, chronic respiratory disease and mental health. This group of conditions is the leading global cause of morbidity and mortality worldwide, with 74% of all deaths globally due to NCDs. 1 Although primary prevention is an essential component of the global health response, there is a need to ensure access to health services and medicines for the millions of individuals with an NCD.2 Targets related to NCDs and access to medicines are included in the Sustainable Development Goals (SDGs) and are key components to achieving universal health coverage (UHC).3 Included in the language of SDG Target 3.b is the notion for people of ‘access to the affordable, high-quality medicines and technologies they need’.4 In exploring the leading causes of inefficiencies in implementing UHC, the WHO reports that many of these relate to the procurement and use of medicines.5

Abstract licence: CC BY-NC

References11

    11 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.